-Hilmi Ozcelik Researcher Activity Profile

Research Author Detailed Information 

Hilmi Ozcelik Publication Rate By Year

Hilmi Ozcelik has published 10 paper(s) in 2007, 3 paper(s) in 2008, for a total of 13 research publications in total.

Hilmi H Ozcelik Author Information

LAST NAME: ozcelik

FIRST NAME: hilmi

INITIALS: H

AFFILIATION:

Papers

Hilmi Ozcelik's Publication Record

1. Genome wide screening of CAG trinucleotide repeat lengths in breast cancer. Year Published: 2007
F. Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ont., Canada.
2. Homologous recombination and prostate cancer: a model for novel DNA repair targets and therapies. Year Published: 2007
Department of Medical Biophysics, University of Toronto and Princess Margaret Hospital (University Health Network), Toronto, Canada. Rob.Bristow@rmp.uhn.on.ca
3. Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario. Year Published: 2007
Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, M5T 3L9, Canada. laurent@mshri.on.ca.
4. Type of TP53 mutation and ERBB2 amplification affects survival in node-negative breast cancer. Year Published: 2007
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray St., Room: 6-303-O, Toronto, ON, Canada, M5T 3L9, ozcelik@mshri.on.ca.
5. Alcohol metabolism, alcohol intake, and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry. Year Published: 2007
Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, Room 724, New York, NY, 10032, USA.
6. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Year Published: 2007
Cancer Research UK, Genetic Epidemiology Unit, Strangeways Research Laboratory, Cambridge, CB1 8RN, UK. antonis@srl.cam.ac.uk
7. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Year Published: 2007
Cancer Research UK, Genetic Epidemiology Unit, Strangeways Research Laboratory, Cambridge, CB1 8RN, UK. antonis@srl.cam.ac.uk
8. Type of TP53 mutation and ERBB2 amplification affects survival in node-negative breast cancer. Year Published: 2007
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray St., Room: 6-303-O, Toronto, ON, Canada, M5T 3L9. ozcelik@mshri.on.ca
9. Biological implications of SNPs in signal peptide domains of human proteins. Year Published: 2008
Fred A. Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
10. Biological implications of SNPs in signal peptide domains of human proteins. Year Published: 2008
Fred A. Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
11. Type of TP53 mutation and ERBB2 amplification affects survival in node-negative breast cancer. Year Published: 2007
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray St., Room: 6-303-O, Toronto, ON, Canada, M5T 3L9. ozcelik@mshri.on.ca
12. Alcohol metabolism, alcohol intake, and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry. Year Published: 2007
Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, Room 724, New York, NY 10032, USA. mt146@columbia.edu
13. Biological implications of SNPs in signal peptide domains of human proteins. Year Published: 2008
Fred A. Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.